NO20065038L - Anvendelse. - Google Patents
Anvendelse.Info
- Publication number
- NO20065038L NO20065038L NO20065038A NO20065038A NO20065038L NO 20065038 L NO20065038 L NO 20065038L NO 20065038 A NO20065038 A NO 20065038A NO 20065038 A NO20065038 A NO 20065038A NO 20065038 L NO20065038 L NO 20065038L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- isomer
- energy balance
- negative energy
- ruminants
- Prior art date
Links
- 241000282849 Ruminantia Species 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000007976 Ketosis Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 230000004140 ketosis Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 208000011580 syndromic disease Diseases 0.000 abstract 2
- 208000004930 Fatty Liver Diseases 0.000 abstract 1
- 206010019708 Hepatic steatosis Diseases 0.000 abstract 1
- 206010046793 Uterine inflammation Diseases 0.000 abstract 1
- 210000001015 abdomen Anatomy 0.000 abstract 1
- 230000036528 appetite Effects 0.000 abstract 1
- 235000019789 appetite Nutrition 0.000 abstract 1
- 238000009109 curative therapy Methods 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 208000010515 dystocia Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000010706 fatty liver disease Diseases 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 208000004396 mastitis Diseases 0.000 abstract 1
- 210000002826 placenta Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57417104P | 2004-05-25 | 2004-05-25 | |
| PCT/IB2005/001438 WO2005115389A2 (en) | 2004-05-25 | 2005-05-13 | Specific ppar agonists for treating negative energy balance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065038L true NO20065038L (no) | 2006-12-01 |
Family
ID=34967765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065038A NO20065038L (no) | 2004-05-25 | 2006-11-02 | Anvendelse. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070281935A1 (ru) |
| EP (1) | EP1753426A2 (ru) |
| JP (1) | JP2008500323A (ru) |
| CN (1) | CN1956719A (ru) |
| AR (1) | AR049185A1 (ru) |
| AU (1) | AU2005247164B2 (ru) |
| BR (1) | BRPI0511481A (ru) |
| CA (1) | CA2567398A1 (ru) |
| IL (1) | IL179244A0 (ru) |
| MX (1) | MXPA06013754A (ru) |
| NO (1) | NO20065038L (ru) |
| RU (1) | RU2353362C2 (ru) |
| TW (1) | TWI280879B (ru) |
| WO (1) | WO2005115389A2 (ru) |
| ZA (1) | ZA200609235B (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0511613A (pt) * | 2004-05-25 | 2008-01-02 | Pfizer Prod Inc | uso de agonista de ppar |
| GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
| US8133901B2 (en) * | 2006-12-01 | 2012-03-13 | Actelion Pharmaceuticals Ltd. | 3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors |
| GB0722769D0 (en) * | 2007-11-21 | 2008-01-02 | Biolipox Ab | New compounds |
| JP2010521444A (ja) * | 2007-03-12 | 2010-06-24 | バイオリポックス エービー | 炎症の治療において有用なピペリジノン類 |
| CA2745643C (en) * | 2008-12-02 | 2015-12-01 | Danisco A/S | A bacillus pumilus strain and methods for improving ruminant health and performance |
| DE102009038123A1 (de) | 2009-08-17 | 2011-02-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| WO2011114103A1 (en) | 2010-03-18 | 2011-09-22 | Biolipox Ab | Pyrimidinones for use as medicaments |
| GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
| CN116162056A (zh) * | 2021-11-24 | 2023-05-26 | 上海医药工业研究院 | β-catenin/BCL9蛋白-蛋白相互作用的小分子抑制剂及其应用 |
| WO2024145931A1 (zh) * | 2023-01-06 | 2024-07-11 | 上海医药工业研究院有限公司 | β-catenin/BCL9蛋白蛋白相互作用的小分子抑制剂及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2340734A1 (fr) * | 1976-02-13 | 1977-09-09 | Roussel Uclaf | Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments |
| US5854211A (en) * | 1993-12-23 | 1998-12-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| DE10238865A1 (de) * | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| CN100439337C (zh) * | 2002-11-26 | 2008-12-03 | 辉瑞产品公司 | 作为ppar活化剂的苯基取代的哌啶化合物 |
| GEP20084393B (en) * | 2003-04-24 | 2008-06-10 | Incyte Corp | Aza spiro alkane derivatives as inhibitors of metalloproteases |
| BRPI0511613A (pt) * | 2004-05-25 | 2008-01-02 | Pfizer Prod Inc | uso de agonista de ppar |
-
2005
- 2005-05-13 RU RU2006141628/15A patent/RU2353362C2/ru not_active IP Right Cessation
- 2005-05-13 WO PCT/IB2005/001438 patent/WO2005115389A2/en not_active Ceased
- 2005-05-13 JP JP2007514167A patent/JP2008500323A/ja active Pending
- 2005-05-13 US US11/569,513 patent/US20070281935A1/en not_active Abandoned
- 2005-05-13 CA CA002567398A patent/CA2567398A1/en not_active Abandoned
- 2005-05-13 CN CNA2005800167704A patent/CN1956719A/zh active Pending
- 2005-05-13 EP EP05738586A patent/EP1753426A2/en not_active Withdrawn
- 2005-05-13 MX MXPA06013754A patent/MXPA06013754A/es unknown
- 2005-05-13 BR BRPI0511481-0A patent/BRPI0511481A/pt not_active IP Right Cessation
- 2005-05-13 AU AU2005247164A patent/AU2005247164B2/en not_active Ceased
- 2005-05-20 TW TW094116567A patent/TWI280879B/zh not_active IP Right Cessation
- 2005-05-23 AR ARP050102112A patent/AR049185A1/es not_active Application Discontinuation
-
2006
- 2006-11-02 NO NO20065038A patent/NO20065038L/no not_active Application Discontinuation
- 2006-11-06 ZA ZA200609235A patent/ZA200609235B/xx unknown
- 2006-11-13 IL IL179244A patent/IL179244A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL179244A0 (en) | 2007-03-08 |
| WO2005115389A2 (en) | 2005-12-08 |
| CA2567398A1 (en) | 2005-12-08 |
| AU2005247164B2 (en) | 2008-11-27 |
| RU2006141628A (ru) | 2008-05-27 |
| ZA200609235B (en) | 2008-08-27 |
| AU2005247164A1 (en) | 2005-12-08 |
| MXPA06013754A (es) | 2007-02-08 |
| EP1753426A2 (en) | 2007-02-21 |
| RU2353362C2 (ru) | 2009-04-27 |
| JP2008500323A (ja) | 2008-01-10 |
| WO2005115389A3 (en) | 2006-11-16 |
| AR049185A1 (es) | 2006-07-05 |
| CN1956719A (zh) | 2007-05-02 |
| BRPI0511481A (pt) | 2007-12-26 |
| TWI280879B (en) | 2007-05-11 |
| US20070281935A1 (en) | 2007-12-06 |
| TW200607501A (en) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20065038L (no) | Anvendelse. | |
| ES2186787T3 (es) | Utilizacion de ritonavir (abt-538) para mejorar la farmacocinetica de medicamentos metabolizados por el citocromo p450 en un metodo de tratamiento del sida. | |
| CR9842A (es) | Composiciones de celecoxib | |
| WO2004066910A3 (en) | Controlled release modifying complex and pharmaceutical compositions thereof | |
| NO20040511L (no) | Aminoisoxazolderivater som kinaseinhibitorer | |
| NO20035139D0 (no) | Karbocykliske hydrazininhibitorer for kobber inneholdende aminoksydaser | |
| US20230233506A1 (en) | Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker | |
| CA2541813A1 (en) | Methods for treating acute and overuse sprain and strain using hyaluronic acid | |
| JP2006503095A (ja) | 反応性関節炎または滑液包炎の治療法 | |
| BR0312123A (pt) | Agentes de gnrh não peptìdicos, composições farmacêuticas e métodos para o seu uso | |
| WO2004039822A3 (en) | 4’’ - modified erythromycin derivatives | |
| RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
| WO2022023533A3 (en) | Antiviral use of liraglutide and gefitinib | |
| WO2004037166A3 (en) | Therapeutic guanidines | |
| DK0561882T3 (da) | Hydroxamsyrederivater, som inhiberer lipoxygenase | |
| WO2023152682A9 (en) | Contraceptive methods with scheduled bleeding effects | |
| WO2003051301A3 (en) | USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY | |
| AR051674A1 (es) | Farmacos y profarmacos utiles para el tratamiento de equilibrio energetico en rumiantes | |
| CN113677682A (zh) | 作为XIa因子抑制剂的大环衍生物 | |
| DK1818052T3 (da) | Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre | |
| RU2006107649A (ru) | Производные 2-алкилиден-19-нор-витамина d для лечения слабости, поражения мышц или саркопении | |
| RU2004132290A (ru) | Способ лечения острого иксодового клещевого боррелиоза на фоне хронического описторхоза | |
| CO2024000737A2 (es) | Anticoncepción oral con progestágeno solo | |
| RU2007125264A (ru) | Способ лечения повреждений слизистой оболочки желудочно-кишечного тракта | |
| BRPI0406580A (pt) | Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |